IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 124 filers reported holding IMMUNITYBIO INC in Q3 2021. The put-call ratio across all filers is 3.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,743,083 | -37.5% | 2,806,183 | +2.8% | 0.00% | 0.0% |
| Q2 2023 | $7,590,656 | +114.3% | 2,730,452 | +40.3% | 0.00% | – |
| Q1 2023 | $3,541,472 | +34303.3% | 1,945,864 | -4.2% | 0.00% | -100.0% |
| Q4 2022 | $10,294 | -99.9% | 2,030,492 | +5.7% | 0.00% | 0.0% |
| Q3 2022 | $9,550,000 | +63.2% | 1,921,589 | +22.2% | 0.00% | 0.0% |
| Q2 2022 | $5,850,000 | -32.6% | 1,572,834 | +1.6% | 0.00% | 0.0% |
| Q1 2022 | $8,684,000 | -8.2% | 1,548,015 | -0.6% | 0.00% | 0.0% |
| Q4 2021 | $9,464,000 | -35.9% | 1,556,601 | +2.7% | 0.00% | -50.0% |
| Q3 2021 | $14,768,000 | -29.6% | 1,516,256 | +3.2% | 0.00% | -33.3% |
| Q2 2021 | $20,987,000 | +33.0% | 1,469,696 | +121.2% | 0.00% | +50.0% |
| Q1 2021 | $15,776,000 | – | 664,549 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Winning Points Advisors, LLC | 236,956 | $879,000 | 0.97% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,249,000 | 0.41% |
| ALLEN HOLDING INC /NY | 687,571 | $2,558,000 | 0.37% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $359,000 | 0.15% |
| SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $773,000 | 0.13% |
| Corton Capital Inc. | 29,032 | $108,000 | 0.10% |
| Clearwater Capital Advisors, LLC | 185,311 | $689,000 | 0.09% |
| Delphia (USA) Inc. | 31,709 | $118,000 | 0.08% |
| Virtus ETF Advisers LLC | 34,799 | $129,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 84,884 | $316,000 | 0.05% |